Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women

The aim of this study was to investigate the prevalence and correlates of peripheral arterial disease (PAD) in a population of osteoporotic postmenopausal women. The presence of PAD was assessed by ankle brachial index (ABI) in 345 ambulatory osteoporotic postmenopausal women, and in 360 community-based, age- and race-matched postmenopausal women with normal bone mineral density (BMD) (control group). PAD was detected in 63/345 (18.2%) osteoporotic women and in 14/360 (3.8%) control subjects (P < 0.0001). The mean ABI values were significantly lower in the osteoporosis group than in the control group (0.98 ± 0.09 vs. 1.04 ± 0.06, P < 0.0001). No difference in cardiovascular risk factors was observed between osteoporotic patients and controls, or between osteoporotic patients with and without PAD. Osteoporotic patients with PAD had lower femoral neck BMD T scores than those without PAD (−4.2 ± 0.7 vs. −2.3 ± 0.7, P < 0.0001). Only 4 PAD patients (5.1%) had intermittent claudication. In multivariate logistic regression analysis, factors independently associated with PAD within osteoporotic patients were lower femoral neck BMD T score (odds ratio (OR) = 0.20, 95% confidence interval (CI), 0.05–0.70, P = 0.01) and systolic blood pressure (OR = 1.02, 95% CI, 1.00–1.03, P = 0.01). This study shows for the first time an increased prevalence of PAD among osteoporotic postmenopausal women, with a lower femoral neck BMD T score being a significant independent predictor. The findings suggest that vascular status evaluation should be done in osteoporotic postmenopausal women in order to identify candidate patients for preventive and therapeutic cardiovascular interventions.

[1]  Stephen W. K. Cheng,et al.  Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  B. Mazières,et al.  Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease , 1994, Clinical Rheumatology.

[3]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[4]  C. Christiansen,et al.  Low Bone Mineral Density in the Hip as a Marker of Advanced Atherosclerosis in Elderly Women , 2003, Calcified Tissue International.

[5]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[6]  L. Raisz.  Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management , 1999, Journal of Bone and Mineral Metabolism.

[7]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[8]  A. Davison,et al.  Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated? , 1992, Journal of the American College of Nutrition.

[9]  C. Vermeer,et al.  Role of K vitamins in the regulation of tissue calcification , 2001, Journal of Bone and Mineral Metabolism.

[10]  R. Langer,et al.  Estrogen Plus Progestin and the Risk of Peripheral Arterial Disease: The Women’s Health Initiative , 2004, Circulation.

[11]  R. Langer,et al.  Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease , 1992 .

[12]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[13]  D. Kiel,et al.  Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham heart study , 2001, Calcified Tissue International.

[14]  S. Humphries,et al.  Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.

[15]  J. Cauley,et al.  Bone Mineral Density and Aortic Calcification: The Study of Osteoporotic Fractures , 1997, Journal of the American Geriatrics Society.

[16]  E. Barengolts,et al.  Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women , 1998, Calcified Tissue International.

[17]  P. Pennisi,et al.  Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. , 2004, Osteoporosis International.

[18]  J. Kanis,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.

[19]  A. Hofman,et al.  Bone Mineral Density and the Risk of Peripheral Arterial Disease: The Rotterdam Study , 2002, Calcified Tissue International.

[20]  OsamuUyama,et al.  Bone Changes and Carotid Atherosclerosis in Postmenopausal Women , 1997 .

[21]  F. Fowkes,et al.  The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. , 1988, International journal of epidemiology.

[22]  A. Hofman,et al.  Increased plasma homocysteine after menopause. , 2000, Atherosclerosis.

[23]  Ivar Heuch,et al.  Low bone mineral density is related to echogenic carotid artery plaques: a population-based study. , 2004, American journal of epidemiology.

[24]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[25]  J. Hsia,et al.  Peripheral Arterial Disease in Randomized Trial of Estrogen With Progestin in Women With Coronary Heart Disease: The Heart and Estrogen/Progestin Replacement Study , 2000, Circulation.

[26]  T. Orchard,et al.  Assessment of Peripheral Vascular Disease in Diabetes Report and Recommendations of an International Workshop* Sponsored by the American Diabetes Association and the American Heart Association September 18‐20, 1992 New Orleans, Louisiana , 1993, Circulation.

[27]  D. Strandness,et al.  Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association , 1993, Diabetes Care.

[28]  A. Olsson,et al.  Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication , 1992, Journal of internal medicine.

[29]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[31]  L. Kauppila.  Prevalence of stenotic changes in arteries supplying the lumbar spine. A postmortem angiographic study on 140 subjects , 1997, Annals of the rheumatic diseases.

[32]  C E Metz,et al.  Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. , 1982, Surgery.

[33]  T. V. van Berkel,et al.  Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential , 2003, Pharmacological Reviews.

[34]  N Rifai,et al.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.

[35]  D L Sackett,et al.  Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. , 1996, Circulation.

[36]  J. Orloff,et al.  Low Bone Density is Not Associated with Aortic Calcification , 2001, Calcified Tissue International.

[37]  Y. Tintut,et al.  Recent advances in multifactorial regulation of vascular calcification , 2001, Current opinion in lipidology.

[38]  Y. Ouchi,et al.  Association of Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism with Bone Mineral Density in Postmenopausal Japanese Women , 2000, Calcified Tissue International.

[39]  T. Drüeke,et al.  Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. , 1999, Kidney international.

[40]  U. Gaspard,et al.  Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. , 1995, Maturitas.

[41]  L. Kuller,et al.  Bone Mineral Density and Blood Flow to the Lower Extremities: The Study of Osteoporotic Fractures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  A. Bradbury,et al.  The validity, reliability, reproducibility and extended utility of ankle to brachial pressure index in current vascular surgical practice. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[43]  T. Mueller,et al.  Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease. , 2004, Journal of vascular surgery.

[44]  I. Reid,et al.  The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.

[45]  M. Seibel,et al.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. , 2001, The Journal of clinical endocrinology and metabolism.

[46]  S. Humphries,et al.  Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. , 2003, The Journal of clinical endocrinology and metabolism.

[47]  G. Sesti,et al.  Relation of low bone mineral density and carotid atherosclerosis in postmenopausal women. , 2004, The American journal of cardiology.

[48]  B. Riggs,et al.  Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. , 1997, Proceedings of the Association of American Physicians.

[49]  L. Taylor.  Hyperhomocyst(e)inaemia: An independent risk factor for intermittent claudication: Molgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG. J Intern Med 1992;231:273–279 , 1993 .

[50]  S. Manolagas.  Bone marrow, cytokines, and bone remodeling , 1995 .

[51]  R. Prescott,et al.  Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. , 1988, Journal of epidemiology and community health.

[52]  P. Ridker,et al.  Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men , 2002, Circulation.